JPRN-UMIN000005918已完成2 期
Phase 2 study of fix dose rate gemcitabine plus S-1 with advanced biliary tract cancer refractory to standard dose rate gemcitabine - Phase 2 study of fix dose rate GEM plus S-1 with advanced BTC refractory to GEM
Yokohama Clinical Oncology Group0 个研究点目标入组 40 人开始时间: 2011年7月5日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Simultaneous or metachronous (within 3 years) double cancers, with the exception of intramucosal tumor curable with local therapy 2) Pregnant or lactating women or women of childbearing potential and men who want to get partner pregnant 3) Psychosis or severe mental disorder 4) Patients requiring systemic steroids medication 5) Plumonary fibrosis or interstitial pneumonia 6) Uncontrollable watery diarrhea 7) Active bacterial or fungous infection 8) Other severe complications such as heart failure, renal failure, liver failure, peptic ulcer, intestinal paralysis, uncontrollable diabetes millitus etc 9) Patients requiring the administration of flucytosine, phenytoin or warfarin potassium 10) Patients who can't receive neither iodic drug nor gadolinium because of drug allergy 11) Prior history of chemotherapy with pyrimidine fluoride for the other disease within the 5 years 12) Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
已完成
2 期
A phase II trial of gemcitabine in a fixed dose rate infusion combined with cisplatin in patients with operable biliary tract carcinomasAdenocarcinoma of the gallbladder or intra/extrahepatic bile ductsCancer - Biliary tree (gall bladder and bile duct)ACTRN12605000001695AGITG/ NHMRC Clinical Trials Centre45
进行中（未招募）
不适用
Phase II trial of the addition of gemcitabine to 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomarelapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-DEAMC47
已完成
2 期
Phase II study of fixed dose rate Gemcitabine-Oxaliplatin Integrated with concomitant 5FU and 3-D Conformal Radiotherapy for the treatment of localised pancreatic cancer: GOFURTGOocally advanced or locally recurrent inoperable pancreatic cancer not previously treated with chemotherapy or radiotherapy.Locally advanced or locally recurrent inoperable pancreatic cancer not previously treated with chemotherapy or radiotherapy.Cancer - PancreaticACTRN12605000026628AGITG45
已完成
2 期
Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.pancreatic cancer with ascitesJPRN-UMIN000003269ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division36
已完成
2 期
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaJPRN-UMIN000021484Clinical study group of Osaka university, Hepato-Biliary- Pancreatic group100